ResearcherHarvard UniversityActive in the last 2 years
Megan L. Sulciner
Matched on ORCID iD 0000-0003-0137-6467; OpenAlex author ID A5087810115. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 1 paper · 2023: none · 2024: 1 paper
Papers 2
- Impact of Tumor Response After Neoadjuvant Treatment on Overall Survival Among Patients With Pancreatic Ductal Adenocarcinoma: National Cancer Database Analysi… Co-author DOI 10.7759/cureus.73524↗
- Advances and Remaining Challenges in the Treatment for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm11164866↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- George Molina · 2 shared papers, 2022–2024 · strength 0.48
- Paper Advances and Remaining Challenges in the Treatment for Borderline Resectable and Locally Advanced Pancreatic Ductal Ade… DOI 10.3390/jcm11164866↗
- Paper Impact of Tumor Response After Neoadjuvant Treatment on Overall Survival Among Patients With Pancreatic Ductal Adenocar… DOI 10.7759/cureus.73524↗
- Stanley W. Ashley · 2 shared papers, 2022–2024 · strength 0.48
- Paper Advances and Remaining Challenges in the Treatment for Borderline Resectable and Locally Advanced Pancreatic Ductal Ade… DOI 10.3390/jcm11164866↗
- Paper Impact of Tumor Response After Neoadjuvant Treatment on Overall Survival Among Patients With Pancreatic Ductal Adenocar… DOI 10.7759/cureus.73524↗
- Thomas E. Clancy · 1 shared paper, 2024 · strength 0.22
- Jason S. Gold · 1 shared paper, 2024 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.